HOWL

Werewolf Therapeutics, Inc.

Latest Form 4:Sale$11KbyEVNIN LUKE (Director) · filed Jul 8, 2026

Werewolf Therapeutics, Inc. (HOWL) has 53 SEC Form 4 filings (163 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.

The most active filer is Director EVNIN LUKE with 87 filings. Insiders have net sold $2.3M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Daniel J. Hicklin
  • Employees:46
  • HQ:Watertown, MA, US
  • IPO:2021-04-30

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$8.7M

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Market Cap

$45.8M

latest known value

Source
Sale$11KJul 8SEC ↗
Sale$33KJul 8SEC ↗
Sale$47KJun 29SEC ↗
Sale$146KJun 22SEC ↗
Sale$68KJun 16SEC ↗
Sale$50KJun 16SEC ↗
Sale$55KJun 16SEC ↗
Sale$137KJun 12SEC ↗
Sale$17KJun 12SEC ↗
Sale$100KJun 12SEC ↗
Sale$28KJun 10SEC ↗
Sale$9KJun 8SEC ↗
Sale$10KJun 8SEC ↗
Sale$24KJun 8SEC ↗
Sale$38KJun 3SEC ↗
Sale$13KJun 3SEC ↗
Sale$12KJun 3SEC ↗
Sale$39KMay 29SEC ↗
Sale$13KMay 29SEC ↗
Sale$15KMay 29SEC ↗
Sale$15KMay 26SEC ↗
Sale$39KMay 26SEC ↗
Sale$32KMay 26SEC ↗
Sale$11KMay 20SEC ↗
Sale$28KMay 20SEC ↗
Sale$37KMay 20SEC ↗
Sale$24KMay 13SEC ↗
Sale$214KMay 12SEC ↗
Sale$23KMay 12SEC ↗
Sale$43KMay 12SEC ↗
Sale$267KMay 12SEC ↗
Sale$59KMay 12SEC ↗
Sale$65KMay 12SEC ↗
Sale$5KMay 7SEC ↗
Sale$10KMay 7SEC ↗
Sale$50KMay 7SEC ↗
Sale$121KMay 4SEC ↗
Sale$43KMay 4SEC ↗
Sale$35KMay 4SEC ↗
EVNIN LUKEFirst in 3 months
Sale$46KApr 29SEC ↗
EVNIN LUKEFirst in 3 months
Sale$70KApr 29SEC ↗
EVNIN LUKEFirst in 3 months
Sale$39KApr 29SEC ↗
Sale$21KJan 20SEC ↗
Sale$24KJan 15SEC ↗
Sale$17KJan 15SEC ↗
Sale$21KJan 15SEC ↗
Sale$5KJan 12SEC ↗
Sale$15KJan 12SEC ↗
Sale$34KJan 12SEC ↗
Sale$12KJan 7SEC ↗
Sale$26KJan 7SEC ↗
Sale$8KJan 7SEC ↗
Sale$21KJan 2SEC ↗
Sale$15KJan 2SEC ↗
Sale$12KJan 2SEC ↗
Sale$41KDec 29SEC ↗
Sale$45KDec 29SEC ↗
Sale$11KDec 29SEC ↗
Sale$22KDec 29SEC ↗
Sale$66KDec 29SEC ↗
Sale$25KDec 17SEC ↗
Sale$15KDec 17SEC ↗
Sale$11KDec 17SEC ↗
Sale$39KDec 12SEC ↗
Sale$30KDec 12SEC ↗
Sale$19KDec 12SEC ↗
Sale$16KDec 9SEC ↗
Sale$34KDec 9SEC ↗
Sale$45KDec 9SEC ↗
Sale$34KDec 4SEC ↗
Sale$32KDec 4SEC ↗
Sale$52KDec 4SEC ↗
Sale$53KDec 4SEC ↗
Sale$50KDec 4SEC ↗
Sale$81KDec 4SEC ↗
Sale$53KDec 4SEC ↗
Sale$50KDec 4SEC ↗
Sale$81KDec 4SEC ↗
Sale$38KDec 1SEC ↗
Sale$13KDec 1SEC ↗
Sale$37KDec 1SEC ↗
Sale$60KDec 1SEC ↗
Sale$20KDec 1SEC ↗
Sale$57KDec 1SEC ↗
Sale$60KDec 1SEC ↗
Sale$20KDec 1SEC ↗
Sale$57KDec 1SEC ↗
Sale$34KNov 25SEC ↗
Sale$56KNov 25SEC ↗
Sale$25KNov 25SEC ↗
Sale$53KNov 25SEC ↗
Sale$87KNov 25SEC ↗
Sale$39KNov 25SEC ↗
Sale$53KNov 25SEC ↗
Sale$87KNov 25SEC ↗
Sale$39KNov 25SEC ↗
Sale$49KNov 20SEC ↗
Sale$62KNov 20SEC ↗
Sale$37KNov 20SEC ↗
Sale$49KNov 20SEC ↗
Sale$62KNov 20SEC ↗
Sale$37KNov 20SEC ↗
Sale$31KNov 20SEC ↗
Sale$40KNov 20SEC ↗
Sale$24KNov 20SEC ↗
Sale$57KNov 17SEC ↗
Sale$37KNov 17SEC ↗
Sale$35KNov 17SEC ↗
Sale$89KNov 17SEC ↗
Sale$57KNov 17SEC ↗
Sale$54KNov 17SEC ↗
Sale$89KNov 17SEC ↗
Sale$57KNov 17SEC ↗
Sale$54KNov 17SEC ↗
Sale$49KNov 12SEC ↗
Sale$37KNov 12SEC ↗
Sale$41KNov 12SEC ↗
Sale$28KNov 12SEC ↗
Sale$76KNov 12SEC ↗
Sale$57KNov 12SEC ↗
Sale$64KNov 12SEC ↗
Sale$44KNov 12SEC ↗
Sale$76KNov 12SEC ↗
Sale$57KNov 12SEC ↗
Sale$64KNov 12SEC ↗
Sale$44KNov 12SEC ↗
Sale$171KNov 6SEC ↗
Sale$58KNov 6SEC ↗
Sale$66KNov 6SEC ↗
Sale$171KNov 6SEC ↗
Sale$58KNov 6SEC ↗
Sale$66KNov 6SEC ↗
Sale$110KNov 6SEC ↗
Sale$38KNov 6SEC ↗
Sale$42KNov 6SEC ↗
Sale$80KNov 3SEC ↗
Sale$94KNov 3SEC ↗
Sale$78KNov 3SEC ↗
Sale$124KNov 3SEC ↗
Sale$146KNov 3SEC ↗
Sale$121KNov 3SEC ↗
Sale$124KNov 3SEC ↗
Sale$146KNov 3SEC ↗
Sale$121KNov 3SEC ↗
Sale$125KOct 29SEC ↗
Sale$113KOct 29SEC ↗
Sale$208KOct 29SEC ↗
GADICKE ANSBERTFirst filing
Sale$125KOct 29SEC ↗
GADICKE ANSBERTFirst filing
Sale$113KOct 29SEC ↗
GADICKE ANSBERTFirst filing
Sale$208KOct 29SEC ↗
EVNIN LUKEFirst filing
Sale$80KOct 29SEC ↗
EVNIN LUKEFirst filing
Sale$73KOct 29SEC ↗
EVNIN LUKEFirst filing
Sale$134KOct 29SEC ↗

Related companies

Werewolf Therapeutics, Inc. is in the Healthcare sector.